Company Filing History:
Years Active: 2025
Title: Alistair James Macnair: Innovator in Anticoagulant Research
Introduction
Alistair James Macnair is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of anticoagulant research, particularly through his innovative work on Factor XIIA inhibitors. His research focuses on developing compounds that can effectively modulate Factor XII, which plays a crucial role in blood coagulation.
Latest Patents
Macnair holds 1 patent related to his work on Factor XIIA inhibitors. This invention pertains to compounds of formula (I) and methods of treatment utilizing these compounds. The compounds are specifically designed to inhibit Factor XIIa, making them potentially useful as anticoagulants. The patent also covers processes and methods for producing these compounds, highlighting their significance in medical applications.
Career Highlights
Alistair James Macnair is affiliated with the University of Leeds, where he continues to advance his research in the field of anticoagulants. His work has garnered attention for its potential to improve treatment options for patients at risk of thrombotic events.
Collaborations
Macnair has collaborated with esteemed colleagues such as Helen Philippou and Richard James Foster. These partnerships have contributed to the depth and breadth of his research, fostering innovation in the development of anticoagulant therapies.
Conclusion
Alistair James Macnair's contributions to the field of anticoagulant research through his innovative patents and collaborations underscore his role as a significant inventor. His work has the potential to impact medical treatments and improve patient outcomes in the future.